Stock Drops 13% After Q1 Earnings

benzinga.com/general/health-care/25/05/45206616/ocular-therapeutix-ocul-stock-drops-13-after-q1-earnings

Ocular Therapeutix Inc (NASDAQ:OCUL) shares are trading lower by 13.3% to $7.63 Monday afternoon after the company reported worse-than-expected first-quarter financial results.
What To Know: Ocular Therapeutix reported first-quarter 2025 results that missed analyst expectations on both…

This story appeared on benzinga.com, 2025-05-05 20:07:39.
The Entire Business World on a Single Page. Free to Use →